Slide background

Slide background
Slide background
Slide background

Loading Events
June
2017
13
Sell Your Science: Best Practices for Developing Effective Non-Confidential Pitch Deck

11:30 AM — 1:00 PM
Featured Presenter: Michelle Hartz | Co-Chair, Golden Seeds   It can be tricky to communicate...
See New York Genome Center’s lecture series, events and archives VIEW FULL CALENDAR

About

Featured Presenter: Michelle Hartz | Co-Chair, Golden Seeds

 

It can be tricky to communicate the full potential of your discoveries without spilling the secret sauce. Join us for sessions on learning the tricks of the trade in preparing a non-confidential deck and executive summary. Experts of the craft will share practical tips on becoming more effective in communicating your story to Angel investors and Venture Capitalists, increasing your chances of successful fundraising.

 

Agenda:
11:30 AM | Registration, Networking and Lunch*
12:00 PM | Presentation
12:45 PM | Q&A
1:00 PM | Program Close
*Light food & beverage provided

 

Who should attend:
This workshop is ideal for inventors in academic centers and hospitals, and early stage healthcare startups in the pharma, medical device, consumer health and digital innovation areas.

 

REGISTER

 

Presenter’s Biography:


Michelle Hartz | Co-Chair, Golden Seeds
Michelle Hartz is the Co-Chair of healthcare sector investments at Golden Seeds, one of the largest angel groups in the United States. In this role, she is deeply immersed in screening, analyzing and helping to shepherd Golden Seeds investment opportunities in health tech, bio/pharma, diagnostics and medical devices.

 

Golden Seeds, one of the nation’s largest and most active angel investment groups in the United States, focuses on funding young companies in which women play a powerful role. Its investment thesis rests on extensive research that concludes that gender diverse teams produce better return on equity. By seeking companies where women hold leadership positions and own substantial equity, Golden Seeds is funding companies that are likely to have diverse perspectives that will contribute to ultimate success.

 

Since 2005, more than 275 Golden Seeds members along with its venture funds have invested over $90 million in more than 85 companies across the country.

 

Michelle is also the Founder of Hartz Consulting, LLC, a business advisory firm that specializes in working with companies that need expertise in the public policy and regulatory arenas. In addition, she is an advisor to young companies and entrepreneurs as they navigate through policy issues that impact their businesses. Over the course of her career, Michelle has been an entrepreneur who founded three successful businesses; a senior corporate executive at major companies; a strategic business advisor to the leadership of the Fortune Global 500, public and private companies, venture capital and private equity firms; a private company board member; an advisor and investor in early stage companies, and co-founder of a pioneering biotechnology company.

 

Michelle began her career with McKinsey & Company in public accounting. Prior to forming Hartz Consulting, LLC, in 2001, she was a managing director of Powell Tate, which she joined at its inception in 1991. Earlier in her career, she was a senior vice president at Burson-Marsteller, where she was responsible for its healthcare practice in Washington, D.C., and at the genesis of Bethesda Research Laboratories, a leading biotechnology company that had a successful exit in the earliest years of the biotechnology gold rush.

 

Michelle is a Phi Beta Kappa Graduate of the University of California at Los Angeles, where she earned an M.B.A., M.A. and B.A.

  • +
    FIVE POINTS

    • Let us go on again, and plunge into the Five Points. — Charles Dickens, 1842

      Named for an early Manhattan crossroads – remembered as a rowdy but cosmopolitan gathering place, and as a nexus for progress in public health – the Five Points Lectures bring outstanding scientists from near and far, to discuss their work in technical detail* with researchers and clinicians from institutions served by NYGC, in order to strengthen our grasp of key biological questions and methods. Speakers present fresh and intriguing findings, along with thoughtful views on their respective fields, in full scientific depth. Talks last roughly 45 minutes — often framing five or so key points, in a nod to the series’ name — followed by 15 minutes of open Q&A, and 30 minutes of networking.

  • +
    WORKSHOP
  • +
    VIDEO ARCHIVE